Organization
Taivex Therapeutics
5 clinical trials
Clinical trial
A Phase I Study of Safety, Tolerability and Pharmacokinetics of T-1101 (Tosylate) Capsules in Subjects With Advanced Refractory Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-07-31
Clinical trial
An Extension Study of T-1101 (Tosylate) Administered Orally to Patients With Advanced Refractory Solid TumorsStatus: Completed, Estimated PCD: 2019-06-24
Clinical trial
A Phase I Safety and Tolerability Study of T-1101 (Tosylate) as a Oral Powder for Constitution (OPC) in Patients With Advanced Refractory Solid TumorsStatus: Terminated, Estimated PCD: 2019-10-01
Clinical trial
A Phase I Study of Safety, Tolerability and Pharmacokinetics of T-1301 Capsules in Subjects With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Phase I, Open-label, Dose-finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of T-1201 Injection 100 mg Kit in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-06-30